The essentially different pharmacodynamic response to colchicine of benign and of malignant epidermal hyperplasia in skin-tumor-resistant RA mice
Kai Setälä
Naturwissenschaften 51(10): 245-246
1964
DOI: 10.1007/bf00641373
Accession: 025784037
PDF emailed within 0-6 h: $19.90
Related References
Setälä, K. 1965: Further evidence of the incompatible pharmacodynamic responses to colchicine of malignant and benign epidermal hyperplasia in mice of skin-tumor resistant strain Die Naturwissenschaften 52(18): 520Setaelae, K. 1965: Differences in Pharmacodynamic Response to Colchicine between Benign and Malignant Epidermal Hyperplasias. An Experimental Study in Skin-Tumor-Resistant Mice Acta Radiologica: Diagnosis 237: Suppl 237:1-89
Setälä, K.; Hujanen, A.; Lindroos, B.; Nyyssönen, O. 1965: Disparities in the modes of pharmacodynamic response to colchicine of malignant and of benign epidermal hyperplasia inskin-tumor-susceptible Swiss CF 1 mice Die Naturwissenschaften 52(18): 519-520
Stjernvall, L.; Niskanen, E.E.; Tarkkanen, J. 1969: Penetration of cytoplasmic barrier in malignant epidermal hyperplasia by colchicine in di methyl sulfoxide a polarization microscopic study in skin tumor resistant mice Acta Radiologica Suppl (294): 5-48
Jiang, Z.-X.; Tan, G.-Z.; Shi, Z.-R.; Zhang, Y.-P.; Han, Y.-F.; Wang, L. 2017: Galectin-3 Expression in Benign and Malignant Skin Diseases with Epidermal Hyperplasia American Journal of Dermatopathology 39(10): 738-741
Setaelae, K.; Lindroos, B.; Nyyssoenen, O. 1964: Effect of Ionizing Radiation on Mitosis in Malignant and Benign Epidermal Hyperplasia in Mice. Vi. Effect of a Single Contact Irradiation after 60 Days of Pretreatment with Carcinogens or Tumor Enhancer Strahlentherapie 123: 99-124
Setaelae, K.; Lindroos, B.; Nyyssoenen, O. 1963: Effect of Ionizing Rays of Mitosis in Malignant and Benign Epidermal Hyperplasia in Mice. V. Effect of a Single Contact Irradiation following a 10-Day Period of Pretreatment with Carcinogens or Tumor-Inducing Agents Strahlentherapie 122: 565-590
Stjernvall, L. 1969: Dimethyl sulfoxide abolishes the carcinogen provoked cytoplasmic barrier of malignant epidermal cells an electron microscopic study with skin tumor resistant mice Annales Medicinae Experimentalis Et Biologiae Fenniae: 253-258
Imamoto, A.; Wang, X.J.; Fujiki, H.; Walker, S.E.; Beltrán, L.M.; DiGiovanni, J. 1993: Comparison of 12-O-tetradecanoylphorbol-13-acetate and teleocidin for induction of epidermal hyperplasia, activation of epidermal PKC isozymes and skin tumor promotion in SENCAR and C57BL/6 mice Carcinogenesis 14(4): 719-724
Flaxman, B.A. 1972: Replication and differentiation in vitro of epidermal cells from normal human skin and from benign (psoriasis) and malignant (basal cell cancer) hyperplasia In Vitro 8(3): 237-255
Setala, K.; Lindroos, B.; Nyyssonen, O. 1963: Effect of ionizing rays on mitosis in malignant and benign epidermal hyperplasia in mice. III. General significance of pathological mitoses in the mouse epidermis Strahlentherapie 121: 97-114
Argyris, T.S. 1980: Tumor promotion by abrasion induced epidermal hyperplasia in the skin of mice Journal of Investigative Dermatology 75(4): 360-362
Argyris, T.S. 1979: Tumor promotion by abrasion induced epidermal hyperplasia in the skin of mice Federation Proceedings 38(3 Part 1): 1073
Greenhalgh, D.A.; Rothnagel, J.A.; Wang, X.J.; Quintanilla, M.I.; Orengo, C.C.; Gagne, T.A.; Bundman, D.S.; Longley, M.A.; Fisher, C.; Roop, D.R. 1993: Hyperplasia, hyperkeratosis and benign tumor production in transgenic mice by a targeted v-fos oncogene suggest a role for fos in epidermal differentiation and neoplasia Oncogene 8(8): 2145-2157
Argyris, T.S. 1983: Nature of the epidermal hyperplasia produced by mezerein, a weak tumor promoter, in initiated skin of mice Cancer Research 43(4): 1768-1773